Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [974]
News [1665]
Articles [150]
Editorials [3]
Conferences [129]
elearning [41]
Cancer care in Latin America
Dr Jean Rene Clemenceau
Cancer care in Latin America ( Dr Jean Rene Clemenceau )
12 Jul 2019
Getting high level care to low and middle income countries
Dr Clifford Hudis and Dr Eduardo Cazap
Getting high level care to low and middle income countries ( Dr Clifford Hudis and Dr Eduardo Cazap )
12 Jul 2019
Guidelines for prepectoral implant-based breast reconstruction
Dr Raghavan Vidya - Royal Wolverhampton Hospital, Wolverhampton, UK
Guidelines for prepectoral implant-based breast reconstruction ( Dr Raghavan Vidya - Royal Wolverhampton Hospital, Wolverhampton, UK )
11 Jul 2019
Latest advances in pancreatic cancer treatment and impact on practice
Prof Eric Van Cutsem and Dr Talia Golan
Latest advances in pancreatic cancer treatment and impact on practice ( Prof Eric Van Cutsem and Dr Talia Golan )
10 Jul 2019
Dose escalation of REGN1979 in patients with relapsed and refractory B-NHL
Prof Max Topp - University of Würzburg, Würzburg, Germany
Dose escalation of REGN1979 in patients with relapsed and refractory B-NHL ( Prof Max Topp - University of Würzburg, Würzburg, Germany )
20 Jun 2019
Controlling CRS-related coagulopathy improves the safety of CAR T-cell therapy...
Dr Heng Mei - Huazhong University of Science and Technology, Wuhan, China
Controlling CRS-related coagulopathy improves the safety of CAR T-cell therapy for MM ( Dr Heng Mei - Huazhong University of Science and Technology, Wuhan, China )
20 Jun 2019
ICARIA results: Treating RRMM patients with isatuximab, pomalidomide and low...
Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA
ICARIA results: Treating RRMM patients with isatuximab, pomalidomide and low-dose dexamethasone ( Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA )
20 Jun 2019
HORIZON update: Using melflufen to treat RRMM patients refractory to...
Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA
HORIZON update: Using melflufen to treat RRMM patients refractory to daratumumab and/or pomalidomide ( Prof Paul Richardson - Dana-Farber Cancer Institute, Boston, USA )
20 Jun 2019
Use of maintenance therapy following ASCT and real world treatment patterns in...
Dr Evangelos Terpos, Prof Michele Cavo, Dr Eloísa Riva, Dr Fredrik Schjesvold
Use of maintenance therapy following ASCT and real world treatment patterns in multiple myeloma ( Dr Evangelos Terpos, Prof Michele Cavo, Dr Eloísa Riva, Dr Fredrik Schjesvold )
15 Jun 2019
Comment: Chemotherapy for frail and elderly patients with advanced...
Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA
Comment: Chemotherapy for frail and elderly patients with advanced gastroesophageal cancer ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )
13 Jun 2019
DORA: Using olaparib alone or with durvalumab in platinum responsive advanced...
Dr Tira Tan - National Cancer Centre, Singapore
DORA: Using olaparib alone or with durvalumab in platinum responsive advanced triple-negative breast cancer ( Dr Tira Tan - National Cancer Centre, Singapore )
12 Jun 2019
ASCO 2019 and vision for cancer control
Dr Eduardo Cazap - Editor-in-Chief, ecancer
ASCO 2019 and vision for cancer control ( Dr Eduardo Cazap - Editor-in-Chief, ecancer )
11 Jun 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation